Itamar Medical Ltd. (NASDAQ:ITMR) is reporting second quarter financial results on Tuesday 11th August 2020, before market open.
According to analysts surveyed by Thomson Reuters, ITMR is expected to report 2Q20 loss of $ 0.19 per share from revenue of $ 7.81 million.
For the full year, analysts anticipate top line of $ 38.17 million, while looking forward to loss of $ 0.51 per share bottom line.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 39.50 million ~ $ 42.00 million
Click Here For More Historical Outlooks Of Itamar Medical Ltd.
Previous Quarter Performance
Itamar Medical Ltd. unveiled loss for the first quarter of $ 0.11 per share, from the revenue of $ 8.38 million. The quarterly earnings escalated 77.78 percent while revenues compared with the same quarter last year.
According to street consensus, ITMR was expected to report 1Q20 loss of $ 0.14 per share from revenue of $ 8.12 million. The bottom line results beat street analysts by $ 0.03 or 21.43 percent, at the same time, top line results outshined analysts by $ 0.26 million or 3.20 percent.
Historical Earnings Performance
wpDataChart with provided ID not found! wpDataTable with provided ID not found!Click Here For More Historical Earnings Of Itamar Medical Ltd.
Stock Performance
According to the previous trading day, closing price of ITMR was $ 25.86, representing a 237.60 % increase from the 52 week low of $ 7.66 and a 10.83 % decrease over the 52 week high of $ 29.00.
The company has a market capital of $ 362.43 million and is part of the Healthcare sector and Medical Devices industry.
[stock_market_widget type=”chart” template=”basic” color=”orange” assets=”ITMR” range=”1y” interval=”1mo” axes=”true” cursor=”true” api=”yf” style=”height: 400px;”]
Conference Call
Itamar Medical Ltd. will be hosting a conference call at 8:00 AM eastern time on 11th August 2020, to discuss its 2Q20 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.itamar-medical.com
Itamar Medical Ltd. engages in the research, development, marketing, sale, and leasing of non-invasive medical devices for the cardiology market in the United States and Canada, Europe, Israel, Japan, the Asia Pacific, and internationally. The company offers medical devices based on Peripheral Arterial Tone (PAT) signal, which measures changes in the patients peripheral arterial pulse volumes and various parameters of arterial activities.
